Engineers at Harvard have developed a 3D printing technique that produces soft robotic structures capable of twisting and ...

Shell is reportedly struggling to recoup its massive investment in Pennsylvania’s petrochemical sector, with weak fourth-quarter returns renewing concerns the project has underdelivered on jobs, ...

Shell is leaning into their NASCAR footprint to give fans a feel a little help beyond the racetrack. Beginning with the start of the 2026 season, the oil ...

Shell PLC is joining the Scene+ reward program later this year, allowing members to use their points on gas and other purchases. Scene+, in an email sent to members earlier this week, said it is ...

BMO Financial Group has announced it will replace Air Miles with a new loyalty rewards program called Blue Rewards this summer. The logo of Blue Rewards is shown in this handout image. THE CANADIAN ...

TORONTO - BMO Financial Group has announced it will replace Air Miles with a new loyalty rewards program called Blue Rewards this summer. *Billed as $4.00 plus GST every four weeks. After 24 weeks, ...

Together with Scotiabank and Tangerine, Shell Introduces New Ways to Save and Earn with Scene+ CALGARY, AB, Jan. 26, 2026 /CNW/ - Shell Canada Limited (Shell), a subsidiary of Shell plc, is joining ...

An international team of researchers has systematically measured the β-decay half-lives of 40 nuclei near calcium-54, providing key experimental data for understanding the structure of extremely ...

TALLAHASSEE, Fla. (WCTV) - College football looks more like its big brother the NFL with each passing season, now with the advent of contracts and direct compensation it’s closer than ever, after a ...

OCEAN SPRINGS, Miss. (WLOX) - New RESTORE Act funding is expanding oyster shell recycling efforts along the Mississippi Gulf Coast, turning discarded shells from local restaurants into tools for ...

The last time I wrote an article on Structure Therapeutics Inc. (GPCR) it was in a Seeking Alpha article entitled "Structure Therapeutics: Potential To Have Best-In-class GLP-1 Agonist For Obesity ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...